NEW YORK STOCK EXCHANGE, INC. · BHVN
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Biohaven Ltd

Biohaven Ltd

Biotechnology
$13.63
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
BHVN
Biohaven Ltd
Wed Aug 5 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

64/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BHVN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BHVN catalysts
About Biohaven Ltd
PHARMACEUTICAL PREPARATIONS
Listed since
2022
Employees
274
Country
US

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$13.63
Last session
Day high
$13.63
Last session
Day low
$13.63
Last session
Previous close
$13.63
52W high
$18.11
-24.74% from high
52W low
$7.79
57% of range
Market cap
$2.1B
EPS
$-6.6300
Beta
0.94
Shares out
150.6M
Avg volume
2.6M
VWAP
$13.63
Last session
Price history computed in-house
1W
-1.37%
1M
-12.35%
3M
+38.24%
1Y
-9.50%
YTD
+20.73%
SMA 50 $13.63 · below
SMA 200 $11.54 · above
52W position 57%

BHVN overview

Veridion Score
64
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BHVN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BHVN Form 4 filings
Public disclosures

Congress activity in BHVN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BHVN in the cached public ledger.

Federal contracts

BHVN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BHVN in this window.
Lobbying spend

BHVN lobbying filings, year to date.

Registered lobbying filings matched to Biohaven Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BHVN in this window.
Loading news for BHVN
Analyst ratings
Sovereign unlock shows live analyst consensus for BHVN.
Options
Sovereign unlock shows live options positioning for BHVN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.